Forester Capital Management’s Pfizer PFE Stock Holding History

Forester Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$3.18M	Sell	99,838 -20,797	-17%	-$656K	4.5%	10
2017 Q1	$3.92M	Sell	120,635 -18,211	-13%	-$574K	4.73%	8
2016 Q4	$4.28M	Sell	138,846 -15,698	-10%	-$479K	4.46%	5
2016 Q3	$4.97M	Sell	154,544 -9,454	-6%	-$316K	4.65%	1
2016 Q2	$5.48M	Buy	163,998 +622	+0.4%	+$19.9K	5.09%	3
2016 Q1	$5.39M	Sell	163,376 -522	-0.3%	-$14.9K	5.03%	1
2015 Q4	$5.02M	Sell	163,898 -84	-0.1%	-$2.64K	4.54%	4
2015 Q3	$4.89M	Sell	163,982 -9,349	-5%	-$300K	4.51%	2
2015 Q2	$5.51M	Buy	173,331 +6,050	+4%	+$197K	4.47%	3
2015 Q1	$5.52M	Sell	167,281 -3,458	-2%	-$110K	4.43%	3
2014 Q4	$5.05M	Buy	170,739 +475	+0.3%	+$13.6K	3.8%	12
2014 Q3	$4.78M	Buy	170,264 +421	+0.2%	+$11.8K	3.73%	8
2014 Q2	$4.78M	Hold	169,843	–	–	3.75%	10
2014 Q1	$5.18M	Hold	169,843	–	–	4.02%	5
2013 Q4	$4.94M	Sell	169,843 -36,289	-18%	-$1.06M	3.93%	6
2013 Q3	$5.62M	Buy	206,132 +32	+0%	+$871	4.46%	2
2013 Q2	$5.48M	Buy	+206,100	New	+$5.69M	4.39%	3

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Forester Capital Management's PFE Position: Q2 2017 in Review

Forester Capital Management reduced its Pfizer (PFE) stake by 17% in Q2 2017, selling an estimated $656K and leaving 99,838 shares worth $3.18M. The position accounts for 4.5% of the portfolio, ranked #10.

Forester Capital Management first reported a position in PFE in Q2 2013 and has held it in 17 quarters since. The position peaked at $5.62M in Q3 2013. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

Forester Capital Management held 99,838 shares of Pfizer worth $3.18M as of Q2 2017.
Forester Capital Management sold 20,797 Pfizer shares in Q2 2017, an estimated $656K.
Pfizer made up 4.5% of Forester Capital Management's portfolio in Q2 2017, its #10 holding.
Forester Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 17 quarters since.
Forester Capital Management's Pfizer position peaked at $5.62M in Q3 2013.
2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Forester Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.